​

Funding Round

Series A - Photys Therapeutics

Series A - Photys Therapeutics

Investment Firm

Overview

Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein modifications.

Announced Date

Sep 08, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

MPM Capital

MPM Capital

MPM Capital is a early_stage_venture and late_stage_venture and private_equity and seed firm.

Participant Investors

8

Investor Name
Participant InvestorEli Lilly & Company Foundation
Participant InvestorLongwood Fund
Participant InvestorMPM Capital
Participant Investor8VC
Participant InvestorOmega Funds

Round Details and Background

Photys Therapeutics raised $75000000 on 2022-09-08 in Series A

Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein modifications.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 08, 2022
Series A - Photys Therapeutics
10-75.0M

Recent Activity

There is no recent news or activity for this profile.